Spectral Medical Inc.

Spectral Medical Inc.

EDTXF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$214.29M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Spectral Medical Inc.Spectral Medical Inc.-769.2-1%--0.4
$-0.20

Current Fair Value

127.4% downside

Overvalued by 127.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$214.29 Million
Enterprise Value$240.26 Million
Earnings per Share$-0.16
Beta0.21
Outstanding Shares294,531,134

Return

Return on Equity0.55%ROE
Return on Assets-11.80%
Return on Invested Capital11.06%

Valuation & Multiples

P/E Ratio-769.23P/E Ratio
PEG658.48PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.73Price to Book Ratio
Enterprise Value to Revenue110.67
Enterprise Value to EBIT-42.23
Enterprise Value to Net Income-686
Total Debt to Enterprise0.11
Debt to Equity-0.42Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 6, 2026
EPS
-$0.01
Est. -$0.01
Revenue
$193,133
Est. $424,189

Next Earnings Call

Expected Date
March 19, 2027
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
$258,001
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Spectral Medical Inc.

29 employees
CEO: Chris Seto

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid...